Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.03.24
/
50%
€1.51
Target price
19.03.25
€3.68
Performance (%)
-8.61%
End price
20.03.25
-
Summary
This prediction is currently being closed. With a performance of -8.61%, the BUY prediction by Chardan_Capital is trending in the wrong direction. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
13.08.25
13.08.25
€28.26
13.08.26
13.08.26
-
14.08.26
14.08.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
15.05.25
15.05.25
€29.48
15.05.26
15.05.26
-
16.05.26
16.05.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
17.04.25
17.04.25
€29.04
17.04.26
17.04.26
-
18.04.26
18.04.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
19.07.24
19.07.24
€36.70
19.07.25
19.07.25
-
20.07.25
20.07.25

